- call +1-201-465-4211
- email sales@mrinsights.biz
Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
Scope of the Report:
This report focuses on the Anti-Obesity Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.
The worldwide market for Anti-Obesity Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
Market Segment by Applications, can be divided into
Hospital Use
Clinic Use
Household
Other
There are 15 Chapters to deeply display the global Anti-Obesity Therapeutics market.
Chapter 1, to describe Anti-Obesity Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Obesity Therapeutics, with sales, revenue, and price of Anti-Obesity Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Obesity Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Obesity Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Obesity Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-Obesity Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Centrally Acting Anti-obesity Drugs
1.2.2 Peripherally Acting Anti-obesity Drugs
1.3 Market Analysis by Applications
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.2 Anti-Obesity Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai Company
2.2.1 Business Overview
2.2.2 Anti-Obesity Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Company Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 FlaxoSithKline plc.
2.3.1 Business Overview
2.3.2 Anti-Obesity Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novo Nordisk
2.4.1 Business Overview
2.4.2 Anti-Obesity Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Alizyme
2.5.1 Business Overview
2.5.2 Anti-Obesity Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Alizyme Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 BoehringerIngelheim GmbH
2.6.1 Business Overview
2.6.2 Anti-Obesity Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Anti-Obesity Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda Pharmaceutical
2.8.1 Business Overview
2.8.2 Anti-Obesity Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Rhythm Pharmaceuticals
2.9.1 Business Overview
2.9.2 Anti-Obesity Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Shionogi USA
2.10.1 Business Overview
2.10.2 Anti-Obesity Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shionogi USA Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Vivus
2.11.1 Business Overview
2.11.2 Anti-Obesity Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Vivus Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Zafgen
2.12.1 Business Overview
2.12.2 Anti-Obesity Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Zafgen Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Norgine Pharmaceuticals Ltd.
2.13.1 Business Overview
2.13.2 Anti-Obesity Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Obesity Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Obesity Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Obesity Therapeutics Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Obesity Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Obesity Therapeutics Market Analysis by Regions
4.1 Global Anti-Obesity Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Obesity Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5 North America Anti-Obesity Therapeutics by Countries
5.1 North America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Anti-Obesity Therapeutics by Countries
6.1 Europe Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Obesity Therapeutics by Countries
7.1 Asia-Pacific Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8 South America Anti-Obesity Therapeutics by Countries
8.1 South America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Obesity Therapeutics by Countries
9.1 Middle East and Africa Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
10 Global Anti-Obesity Therapeutics Market Segment by Type
10.1 Global Anti-Obesity Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Obesity Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Centrally Acting Anti-obesity Drugs Sales Growth and Price
10.2.1 Global Centrally Acting Anti-obesity Drugs Sales Growth (2013-2018)
10.2.2 Global Centrally Acting Anti-obesity Drugs Price (2013-2018)
10.3 Peripherally Acting Anti-obesity Drugs Sales Growth and Price
10.3.1 Global Peripherally Acting Anti-obesity Drugs Sales Growth (2013-2018)
10.3.2 Global Peripherally Acting Anti-obesity Drugs Price (2013-2018)
11 Global Anti-Obesity Therapeutics Market Segment by Application
11.1 Global Anti-Obesity Therapeutics Sales Market Share by Application (2013-2018)
11.2 Hospital Use Sales Growth (2013-2018)
11.3 Clinic Use Sales Growth (2013-2018)
11.4 Household Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.1 Global Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Obesity Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.4 South America Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Obesity Therapeutics Market Forecast (2018-2023)
12.3 Anti-Obesity Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Obesity Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Obesity Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Anti-Obesity Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Obesity Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Obesity Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Obesity Therapeutics Picture
Table Product Specifications of Anti-Obesity Therapeutics
Figure Global Sales Market Share of Anti-Obesity Therapeutics by Types in
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
